IMMUNOGEN INC·4

Aug 4, 11:44 AM ET

IMMUNOGEN INC 4

4 · IMMUNOGEN INC · Filed Aug 4, 2015

Insider Transaction Report

Form 4
Period: 2015-08-03
Johnston David Brannon
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2015-08-03$17.04/sh5,000$85,1800 total
  • Exercise/Conversion

    Common Stock

    2015-08-03$10.79/sh+5,000$53,9505,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-08-03$10.79/sh5,000$53,95095,000 total
    Exercise: $10.79From: 2015-07-17Exp: 2024-07-17Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]Weighted average price of shares sold
  • [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 16, 2015.
  • [F3]Exercisable as to 33,334 shares commencing on July 17, 2015, 33,333 shares commencing on July 17, 2016, and 33,333 shares commencing on July 17, 2017.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -